SPACeR Group is the research arm of the Royal Surrey County Hospital’s Anaesthetics & Intensive Care Departments. We are a multi-disciplinary team of professionals committed to advanced of patient care through clinical research. We undertake interventional, observational, investigational medicinal and commercial research trials that are locally developed or in collaboration with other sites, both national and international.
SPACeR was formed in January 2013. However research activity in the department of anaesthesia and intensive care medicine long preceded this. In November 2013 we were selected to become a Clinical Academic Group, in partnership with the University of Surrey and Ashford and St. Peter’s NHS Foundation Trust.
The Royal Surrey County Hospital (RSCH) NHS Foundation Trust is a leading modern general hospital and specialist centre for cancer services and treatment, based in Guildford. The RSCH serves a population of 320,000 for emergency and general hospital services, mainly from West Surrey, East Hampshire and North Sussex and 1.2 million people for cancer services. There are 527 beds.
We were appointed the host organisation for the National Institute for Health Research (NIHR) Clinical Research Network for Kent, Surrey and Sussex (KSS) in Autumn 2013.
The University of Surrey is a campus-university adjacent to RSCH. It is consistently climbing the league tables and is keen to further develop its biomedical faculties. We have established collaborations with investigators across several departments. Professor Tom Quinn is both the academic chair of SPACeR CAG and the associate dean for health and medical strategy at the University. The University hosts the local NIHR research design service.
A neighbouring NHS trust that is becoming more closely affiliated with RSCH and is a partner in the Clinical Academic Group (CAG). Dr Ian White is the clinical chair representing ASPH in the CAG.
Critical care at RSCH
The Intensive Care Unit (ICU) currently has 25 beds following a recent expansion. The unit is mixed level 2 (HDU) and level 3 (ICU) and ~60% of the patients are surgical. Last year we had >1100 admissions. The Unit is covered 24/7 by three tiers of trainee doctors. It is recognised for training at intermediate and advanced levels. There are fellows in acute imaging and clinical research.
Theatres at RSCH
RSCH is a major surgical oncology centre with tertiary services for hepatopancreaticobiliary, oesophagogastric, and head/neck surgery. There is specialist expertise in regional anaesthesia and the management of difficult airway. The Minimal Access Therapy Training Unit is an internationally recognised centre of excellence for the teaching of innovative laparoscopic and robotic surgical techniques and is on site. There are 35 consultant anaesthetists and 14 operating theatres. There are fellows in difficult airways and clinical research (high risk surgery).
We have a state-of-the-art simulation suite. Medisim website here.
Cardiopulmonary exercise testing (CPX)
As a major high-risk surgical centre with a well-established CPX service we’ve vast experience and have assessed more than 600 patients with CPX prior to surgery. More information soon…
Imaging: echocardiography and ultrasonography
We aim to be the first ICU in the UK with every consultant accredited with the latest Intensive Care Society’s FICE (Focused Intensive Care Echocardiography) scheme. We have a senior ICU-based echocardiographer on a part-time basis and have a full-time acute imaging fellow. We offer FICE and the new CUSIC accreditation to every advanced ICM trainee who works with us.